We are live on ! Find out more
PAM

Panagora Asset Management Portfolio holdings

AUM $26.7B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+1.89%
1 Year Est. Return
+36.4%
3 Year Est. Return
+128.64%
5 Year Est. Return
+186.75%
10 Year Est. Return
+733.24%
AUM
$20.1B
AUM Growth
-$150M
Cap. Flow
-$159M
Cap. Flow %
-0.79%
Top 10 Hldgs %
16.82%
Holding
2,444
New
140
Increased
905
Reduced
734
Closed
149

Top Buys

Rank Stock Value
1
GIS icon
General Mills
GIS
+$68.7M
2
DD icon
DuPont de Nemours
DD
+$63.4M
3
VZ icon
Verizon
VZ
+$48.6M
4
TGT icon
Target
TGT
+$47.7M
5
AAL icon
American Airlines Group
AAL
+$47.7M

Top Sells

Rank Stock Value
1
GD icon
General Dynamics
GD
+$90.1M
2
CVS icon
CVS Health
CVS
+$56.7M
3
ABBV icon
AbbVie
ABBV
+$49.1M
4
APTV icon
Aptiv
APTV
+$49M
5
BSX icon
Boston Scientific
BSX
+$47.3M

Sector Composition

Rank Sector Weight
1 Technology 15.9%
2 Healthcare 14.1%
3 Financials 11.88%
4 Consumer Discretionary 10.09%
5 Industrials 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AERI
2351
DELISTED
Aerie Pharmaceuticals
AERI
-1,689
Closed -$41K
GBT
2352
DELISTED
Global Blood Therapeutics, Inc.
GBT
-5,908
Closed -$191K
AMPE
2353
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-36
Closed -$38K
EPZM
2354
DELISTED
Epizyme, Inc
EPZM
-3,573
Closed -$57K
SRRA
2355
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-45
Closed -$27K
DRNA
2356
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-6,819
Closed -$81K
ADXS
2357
DELISTED
Advaxis Inc
ADXS
-337
Closed -$51K
FLXN
2358
DELISTED
Flexion Therapeutics, Inc.
FLXN
-1,807
Closed -$35K
SNR
2359
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
-57,786
Closed -$570K
CUB
2360
DELISTED
Cubic Corporation
CUB
-7,006
Closed -$331K
TPCO
2361
DELISTED
Tribune Publishing Company Common Stock
TPCO
-34,213
Closed -$315K
AIMT
2362
DELISTED
Aimmune Therapeutics
AIMT
-6,375
Closed -$118K
PFNX
2363
DELISTED
Pfenex Inc.
PFNX
-4,685
Closed -$58K
IPHS
2364
DELISTED
Innophos Holdings, Inc.
IPHS
-16,826
Closed -$488K
ACHN
2365
DELISTED
Achillion Pharmaceuticals
ACHN
-1,969
Closed -$21K
BKS
2366
DELISTED
Barnes & Noble
BKS
-133,893
Closed -$1.17M
PETX
2367
DELISTED
Aratana Therapeutics, Inc.
PETX
-6,350
Closed -$35K
LABL
2368
DELISTED
Multi-Color Corp
LABL
-7,840
Closed -$469K
ELGX
2369
DELISTED
Endologix Inc
ELGX
-243
Closed -$24K
LOXO
2370
DELISTED
Loxo Oncology, Inc
LOXO
-2,043
Closed -$58K
CYHHZ
2371
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$0 ﹤0.01%
4,800
GNBC
2372
DELISTED
Green Bancorp, Inc
GNBC
-6,069
Closed -$64K
PF
2373
DELISTED
Pinnacle Foods, Inc.
PF
-9,707
Closed -$412K
ANTH
2374
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
-1,668
Closed -$62K
CASC
2375
DELISTED
Cascadian Therapeutics, Inc.
CASC
-7,372
Closed -$98K

Similar funds

Panagora Asset Management's Q1 2016 Portfolio in Review

As of Q1 2016, Panagora Asset Management held 2,444 positions worth $20.1B, down 0.74% from $20.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Panagora Asset Management's Q1 2016 filing shows 140 new, 905 increased, 734 reduced and 149 closed positions. Its largest new stake was Avangrid, Inc.: 318,220 shares worth $12.8M. The largest sale was General Dynamics, an estimated $90.1M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Panagora Asset Management's largest Q1 2016 buy was Avangrid, Inc.: 318,220 shares worth $12.8M.
  • Panagora Asset Management added most to General Mills in Q1 2016, an estimated $68.7M increase.
  • Panagora Asset Management's biggest Q1 2016 reduction was General Dynamics, cutting an estimated $90.1M.
  • Panagora Asset Management fully exited HEALTH NET INC in Q1 2016, selling an estimated $23.5M.
  • Panagora Asset Management's ten largest holdings make up 17% of its $20.1B portfolio in Q1 2016.
  • Panagora Asset Management opened 140 new positions and closed 149 in Q1 2016.
  • Panagora Asset Management's portfolio value fell 0.74% quarter-over-quarter to $20.1B.

Based on Panagora Asset Management's 13F filing for Q1 2016, filed 16 May 2016.